(Q44264318)

English

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

Surya P Ayalasomayajula

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Uday B Kompella

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

458

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

283-289

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Is diabetic retinopathy an inflammatory disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

VEGF localisation in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Expression of constitutive cyclo-oxygenase (COX-1) in rats with streptozotocin-induced diabetes; effects of treatment with evening primrose oil or an aldose reductase inhibitor on COX-1 mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Histopathology of diabetic retinopathy in man

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Kinetic basis for selective inhibition of cyclo-oxygenases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Evolution of Streptozotocin–Pancreatic Damage in the Rat: Modulatory Effect of Endothelins on the Nitridergic and Prostanoid Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Celecoxib: a specific COX-2 inhibitor with anticancer properties

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Studies on Salicylates and Complement in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Protein levels in the vitreous of rats with streptozotocin-induced diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Effects of high glucose concentration and a thromboxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by cultured retinal endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902793-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(02)02793-0

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44264318&oldid=2108989996"